NCT00625703 Pharmacokinetics of Linezolid in Children With Cystic Fibrosis Status COMPLETED Phase PHASE2
NCT00625612 Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease Status COMPLETED Phase PHASE3
NCT00590538 Phenylbutyrate/Genistein Duotherapy in Delta F508-Heterozygotes (for Cystic Fibrosis) Status TERMINATED Phase PHASE1/PHASE2
NCT00590330 Microbial Community Composition and Dynamics in Lungs of Cystic Fibrosis Sibling Pairs Status COMPLETED Phase N/A
NCT00589745 Nasal Potential Difference (NPD) for the Diagnosis of Cystic Fibrosis Status COMPLETED Phase NA
NCT00585364 Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA Status COMPLETED Phase N/A
NCT00577499 Effect of Lubiprostone on Nutritional Status and Pulmonary Function in Adults With Cystic Fibrosis Status TERMINATED Phase N/A
NCT00577252 Coping Compliance and Adjustment in Adolescents With Cystic Fibrosis Status COMPLETED Phase N/A
NCT00572975 Malabsorption Blood Test:Toward a Novel Approach to Quantify Steatorrhea Status COMPLETED Phase PHASE4
NCT00570349 Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis Status COMPLETED Phase PHASE1/PHASE2
NCT00558844 Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa Status COMPLETED Phase PHASE1/PHASE2
NCT00557089 The Effect of rhDNase on Ventilation Inhomogeneity in Patients With Cystic Fibrosis Status COMPLETED Phase PHASE4
NCT00547053 Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis Status COMPLETED Phase PHASE1
NCT00546663 Tolerability of Inhaled Hypertonic Saline in Infants With Cystic Fibrosis Status COMPLETED Phase NA